Human miR-221222 in Physiological and Atherosclerotic Vascular Remodeling

Abstract EN

A cluster of miR-221/222 is a key player in vascular biology through exhibiting its effects on vascular smooth muscle cells (VSMCs) and endothelial cells (ECs).

These miRNAs contribute to vascular remodeling, an adaptive process involving phenotypic and behavioral changes in vascular cells in response to vascular injury.

In proliferative vascular diseases such as atherosclerosis, pathological vascular remodeling plays a prominent role.

The miR-221/222 cluster controls development and differentiation of ECs but inhibits their proangiogenic activation, proliferation, and migration.

miR-221/222 are primarily implicated in maintaining endothelial integrity and supporting quiescent EC phenotype.

Vascular expression of miR-221/222 is upregulated in initial atherogenic stages causing inhibition of angiogenic recruitment of ECs and increasing endothelial dysfunction and EC apoptosis.

In contrast, these miRNAs stimulate VSMCs and switching from the VSMC “contractile” phenotype to the “synthetic” phenotype associated with induction of proliferation and motility.

In atherosclerotic vessels, miR-221/222 drive neointima formation.

Both miRNAs contribute to atherogenic calcification of VSMCs.

In advanced plaques, chronic inflammation downregulates miR-221/222 expression in ECs that in turn could activate intralesion neoangiogenesis.

In addition, both miRNAs could contribute to cardiovascular pathology through their effects on fat and glucose metabolism in nonvascular tissues such as adipose tissue, liver, and skeletal muscles.